Navigation Links
Biocartis Strengthens Management Team With Chief Commercial Officer

LAUSANNE, Switzerland and MECHELEN, Belgium, September 4, 2013 /PRNewswire/ --

Biocartis, a molecular diagnostics company, announces today that Ulrik Cordes has joined the company as Chief Commercial Officer (CCO). Ulrik Cordes is an executive with 18+ years of experience in marketing and sales in the med-tech, pharma and biotech industry, of which the past 10 years in top level management roles.

"We are delighted to welcome Ulrik to Biocartis' Executive Team," said RudiPauwels, CEO and Chairman  of Biocartis. "We are transforming from a development company into a commercial business. The addition of Ulrik will be key to achieving our ultimate goal to making personalized medicine a day-to- day reality by building a global business. Ulrik possesses a unique combination of experience and success in building winning commercial strategies and attracting world class sales and sales support professionals."

Ulrik Cordes joins Biocartis most recently from Thermo Fisher Scientific, where he held the position of Global Sales & Marketing Director Slides & Specialty Glass since March 2012. Since 2002 Ulrik worked at DAKO A/S - A World-leading Company in Cancer Diagnostics, where he held a number of positions with increasing responsibility, most recently as Vice President Marketing Operations and Vice President Asia Pacific & Export Region.

He started his career in 1995 in Pharmacia Biotech A/S (now part of GE Healthcare). Ulrik received his Master of Science in Biochemistry from the University of Copenhagen and holds a Bachelor of Commerce (HD) from Copenhagen Business School.

About Biocartis (
Biocartis aims to improve healthcare outcomes by enabling the practice of personalized medicine anywhere, anytime. Biocartis' ambition is to establish a new gold standard in diagnostic testing. Biocartis' innovative research and diagnostic systems are characterized by multiplex detection and simplified workflows which require less hands-on time and minimize sample requirements (especially for tumor biopsies). Additionally, Biocartis develops assays which have high clinical utility and compelling health economic value. Oncology is the primary focus of Biocartis as this is one of the greatest unmet needs for personalized medicine. Biocartis is well suited to address the growing need for individualized diagnosis and treatment of cancer patients.

Biocartis is a rapidly growing company; to date Biocartis staff includes over 170 people.

SOURCE Biocartis NV
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Biocartis versterkt managementteam met commercieel directeur
2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
3. Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
4. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
5. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
6. Actinium Pharmaceuticals Strengthens Management Team
7. Pharmalink AB Strengthens Senior Management Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. inVentiv Health Strengthens Clinical Leadership Team
10. Alliqua Strengthens and Realigns Executive Team
11. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
Post Your Comments:
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... in intelligent sensors and analytic software for sensor network-based systems, announced the OS-3008 with OleaSense ... signs. Photo - Logo - ... ... ... This wireless, contactless ...
(Date:12/1/2015)... 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast to ... ) has announced the addition of ... Forecast to 2020" report to their offering. ... ) has announced the addition of the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Florida Hospital Tampa is the first health care provider in the region to offer ... Therapy is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of ... at least 40 to 45 kg, or a BMI of at least 35 to 39.9 ...
(Date:12/1/2015)... ... 2015 , ... Dr. Paul Vitenas, one of the top cosmetic surgeons ... magazine as the Best Single Physician Practice in the nation. Dr. Vitenas and his ... honored by the industry publication. , Dr. Vitenas said he was very honored ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today ... Golden Bridge Business Awards under the New Products and Services category for its ... sample management software that helps labs organize data and track samples ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... 01, 2015 , ... McLean, VA., December 1, 2015 - ... per sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT ... software engineering, infrastructure, as well as operations and sustainment support to the NGA’s ...
Breaking Medicine News(10 mins):